Drugs stocks advanced on Wall Street Tuesday with the speculation that the pending health care plan may be disrupted if Republicans win a Senate seat in Massachusetts. The European Stock market closed higher on the upswing.
The European stocks had been trading low all day on Tuesday before the news from the U.S. about less than ideal corporate earnings. At closing, the FTSE 100 index of British shares gained 18.75 points, or 0.3 percent, at 5,513.14. Germany's DAX tacked on 57.93 points, or 1 percent, to reach 5,976.48. France’s CAC-40 rose 32.21 points to hit 4,009.675.
Merck & Co. and Pfizer Inc. both made significant gains on Tuesday, ahead on the Dow leader board and followed closely by Johnson & Johnson.
About EQUITIES:
Since 1951, EQUITIES Magazine has been a leading media company providing business editorial content designed to serve the needs of business leaders, professionals, institutional investors and retail investors. We are focused on business and the business of making money, not on lifestyle subjects. We publish original reporting in print and on our website, as well as select content at www.nasdaq.com. For 28 years we have hosted our own branded investor conferences that connect public company CEO’s with our loyal readers in the investment community.
Sign up for a free one-year subscription
